{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:40:53Z","timestamp":1781134853213,"version":"3.54.1"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>We compared hospitalization outcomes in infants with neonatal opioid withdrawal syndrome (NOWS) treated with a novel symptom-triggered methadone approach (STMA) versus a fixed-schedule methadone taper (FSMT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This was a single-center quality-improvement study of infants pharmacologically treated for NOWS. Outcomes were compared over time by using statistical process control charts and between the baseline FSMT (July 2016\u2013November 2017) and intervention STMA (December 2017\u2013May 2018) groups, including median hospital length of stay (LOS), methadone treatment days, total milligrams of methadone, and need for adjunctive agents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>There were 48 infants in the FSMT group and 28 in the STMA group. Infants treated with STMA had a median LOS of 10.5 days (interquartile range [IQR] 10.5) versus 17.0 days (IQR 3.9; P = .003) in the FSMT group, with a 9.2-day difference in methadone treatment days (2.5 [IQR 9.0] vs 11.7 [IQR 4.0]; P = .0001), meeting criteria for statistical process control special cause variation. The average number of symptom-triggered doses was 2.1 (SD 1.0). Six infants in the STMA group were converted to FSMT after failing a trial of STMA. Infants successfully treated with the STMA (N = 22) had a median LOS of 10.0 days (IQR 4.0) compared with 17.0 (IQR 3.9) in the baseline FSMT group (P &amp;lt; .0001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>STMA was associated with a significant reduction in median LOS and amount of methadone treatment. A symptom-triggered approach to NOWS may reduce LOS and medication exposure.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2018-0165","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T13:25:21Z","timestamp":1564665921000},"page":"576-584","source":"Crossref","is-referenced-by-count":17,"title":["Standard Fixed-Schedule Methadone Taper Versus Symptom-Triggered Methadone Approach for Treatment of Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1542","volume":"9","author":[{"given":"Elisha M.","family":"Wachman","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Minear","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meshelle","family":"Hirashima","sequence":"additional","affiliation":[{"name":"Schools of Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hansbury","sequence":"additional","affiliation":[{"name":"Public Health, Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hutton","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"},{"name":"Medicine, Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginny","family":"Combs","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Barry","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Slater","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Stickney","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y.","family":"Walley","sequence":"additional","affiliation":[{"name":"Medicine, Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"issue":"13","key":"2021120817101263100_B1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"2021120817101263100_B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1542\/hpeds.2017-0077","article-title":"Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016","volume":"8","author":"Milliren","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"8","key":"2021120817101263100_B3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/jp.2015.63","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 [published correction appears in J Perinatol. 2015;35(8):650\u2013655]","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"issue":"22","key":"2021120817101263100_B4","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120817101263100_B5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"8","key":"2021120817101263100_B6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome","volume":"38","author":"Wachman","year":"2018","journal-title":"J Perinatol"},{"issue":"1","key":"2021120817101263100_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"6","key":"2021120817101263100_B8","doi-asserted-by":"crossref","first-page":"e20163360","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"2021120817101263100_B9","article-title":"Neonatal drug withdrawal [published correction appears in Pediatrics. 2014;133(5):937]","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"2021120817101263100_B10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13669-016-0168-9","article-title":"Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment","volume":"5","author":"Saia","year":"2016","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"10","key":"2021120817101263100_B11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch Intern Med"},{"issue":"7","key":"2021120817101263100_B12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1994.03520070039035","article-title":"Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial","volume":"272","author":"Saitz","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"2021120817101263100_B13","first-page":"CD005064","article-title":"Anticonvulsants for alcohol withdrawal","volume":"17","author":"Minozzi","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2021120817101263100_B14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/jp.2014.194","article-title":"Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial","volume":"35","author":"Brown","year":"2015","journal-title":"J Perinatol"},{"issue":"8","key":"2021120817101263100_B15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2021120817101263100_B16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/qhc.12.6.458","article-title":"Statistical process control as a tool for research and healthcare improvement","volume":"12","author":"Benneyan","year":"2003","journal-title":"Qual Saf Health Care"},{"issue":"5","key":"2021120817101263100_B17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/dev.21532","article-title":"Neonatal abstinence syndrome: neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal","volume":"59","author":"Heller","year":"2017","journal-title":"Dev Psychobiol"},{"issue":"5","key":"2021120817101263100_B18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-199405000-00009","article-title":"Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion","volume":"22","author":"Katz","year":"1994","journal-title":"Crit Care Med"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/9\/8\/576\/815981\/hpeds_2018-0165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/9\/8\/576\/815981\/hpeds_2018-0165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T17:27:13Z","timestamp":1638984433000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/9\/8\/576\/26815\/Standard-Fixed-Schedule-Methadone-Taper-Versus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":18,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,1]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2018-0165","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}